Marksans Pharma Limited
Microcap 250
₹329.40
-0.30%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.11.
- Comfortable interest cover: operating profit covers interest about 25 times.
- Return on equity is healthy at 15.2%.
- Return on capital employed is healthy at 18.8%.
- Net profit margin is 14.2%.
- Profit has compounded about 12% a year over five years.
- Sales have compounded about 16% a year over five years.
- Pays a dividend (yield about 0.27%).
- Has paid a dividend in each of the last 5 years on record.
- Promoters hold a sizeable stake (43.87%).
!Watch-points
No notable watch-points flagged by the automated checks.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
4.68
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
5 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 14,927 Cr
Current Price₹ 329.40
High / Low₹ 349.95 / 155.00
Stock P/E28.894737
Book Value₹ 66.70
Dividend Yield0%
ROCE18.80%
ROE15.20%
Face Value₹ 1.00
Debt to Equity0.11
PEG Ratio1.81
EV / EBITDA21.81
Industry PE35.70
P/B Ratio4.9376426
EPS₹ 9.22
Debt₹ 343 Cr
PAT Margin14.23%
Cash PAT₹ 519 Cr
ICR25.04
Promoter Holding43.87%
FII Holding17.47%
DII Holding6.19%
Public Holding32.46%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity